Medicamentos Especiales
La presente Base Administrativa y documentación de Licitación Pública anexada al Portal Mercado Público, tiene por objeto regular los procesos de: Licitación Pública, Apertura, Evaluación, Adjudicación, Ejecución, Recepción y Puesta en Marcha del Contrato
16 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2080-11216-SE14 | 31-12-2014 | Astrazeneca S.A. | $124.950 |
| 2080-11113-SE14 | 23-12-2014 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-9601-SE14 | 07-11-2014 | Fresenius Kabi Chile Limitada | $5.712.000 |
| 2080-9381-SE14 | 29-10-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $528.360 |
| 2080-8920-SE14 | 15-10-2014 | Astrazeneca S.A. | $124.950 |
| 2080-8630-SE14 | 07-10-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-8517-SE14 | 01-10-2014 | Laboratorios Rider Limitada | $149.940 |
| 2080-7973-SE14 | 09-09-2014 | Laboratorios Rider Limitada | $74.970 |
| 2080-6663-SE14 | 01-08-2014 | Astrazeneca S.A. | $124.950 |
| 2080-6475-SE14 | 28-07-2014 | Laboratorios Rider Limitada | $49.980 |
| 2080-6354-SE14 | 25-07-2014 | Tecnofarma S.A. | $1.085.280 |
| 2080-6396-SE14 | 25-07-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-4364-SE14 | 02-07-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-5207-SE14 | 27-06-2014 | Tecnofarma S.A. | $283.220 |
| 2080-5217-SE14 | 27-06-2014 | Laboratorios Rider Limitada | $99.960 |
| 2080-4524-SE14 | 06-06-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $845.376 |
| 2080-4361-SE14 | 02-06-2014 | Astrazeneca S.A. | $124.950 |
| 2080-4363-SE14 | 02-06-2014 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-4343-SE14 | 02-06-2014 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-4338-SE14 | 02-06-2014 | Tecnofarma S.A. | $461.720 |
| 2080-4260-SE14 | 27-05-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-4029-SE14 | 13-05-2014 | Etex Farmaceutica Limitada | $243.950 |
| 2080-3900-SE14 | 08-05-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-3834-SE14 | 06-05-2014 | Laboratorios Recalcine S.A. | $54.740 |
| 2080-3029-SE14 | 09-04-2014 | Laboratorios Rider Limitada | $99.960 |
| 2080-3041-SE14 | 09-04-2014 | Tecnofarma S.A. | $283.220 |
| 2080-3040-SE14 | 09-04-2014 | Tecnofarma S.A. | $178.500 |
| 2080-2831-SE14 | 31-03-2014 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-2632-SE14 | 25-03-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-2240-SE14 | 13-03-2014 | Astrazeneca S.A. | $262.395 |
| 2080-2182-SE14 | 10-03-2014 | Laboratorios Recalcine S.A. | $54.740 |
| 2080-2056-SE14 | 10-03-2014 | Pfizer Chile S.A. | $1.785.000 |
| 2080-1568-SE14 | 17-02-2014 | Pfizer Chile S.A. | $1.785.000 |
| 2080-1312-SE14 | 11-02-2014 | Tecnofarma S.A. | $404.600 |
| 2080-1353-SE14 | 11-02-2014 | Laboratorios Recalcine S.A. | $54.740 |
| 2080-1080-SE14 | 04-02-2014 | Tecnofarma S.A. | $380.324 |
| 2080-980-SE14 | 29-01-2014 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-859-SE14 | 28-01-2014 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-751-SE14 | 24-01-2014 | Pfizer Chile S.A. | $1.785.000 |
| 2080-133-SE14 | 07-01-2014 | Glaxosmithkline Chile Farmaceutica Limitada | $845.376 |
| 2080-29-SE14 | 07-01-2014 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-10914-SE13 | 02-01-2014 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-11064-SE13 | 02-01-2014 | Tecnofarma S.A. | $283.220 |
| 2080-10813-SE13 | 16-12-2013 | Etex Farmaceutica Limitada | $243.950 |
| 2080-10558-SE13 | 04-12-2013 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-10504-SE13 | 03-12-2013 | Pfizer Chile S.A. | $1.309.000 |
| 2080-10296-SE13 | 03-12-2013 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-10500-SE13 | 03-12-2013 | Fresenius Kabi Chile Limitada | $952.000 |
| 2080-10197-SE13 | 22-11-2013 | Laboratorios Rider Limitada | $114.954 |
| 2080-10175-SE13 | 21-11-2013 | Tecnofarma S.A. | $404.600 |
| 2080-10039-SE13 | 18-11-2013 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-6079-SE13 | 30-10-2013 | Glaxosmithkline Chile Farmaceutica Limitada | $422.688 |
| 2080-9159-SE13 | 24-10-2013 | Laboratorios Recalcine S.A. | $459.816 |
| 2080-9134-SE13 | 23-10-2013 | Tecnofarma S.A. | $357.000 |
| 2080-9240-SE13 | 23-10-2013 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-9175-SE13 | 22-10-2013 | Pfizer Chile S.A. | $1.309.000 |
| 2080-8906-SE13 | 16-10-2013 | Astrazeneca S.A. | $262.395 |
| 2080-8259-SE13 | 27-09-2013 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-8080-SE13 | 13-09-2013 | Tecnofarma S.A. | $323.680 |
| 2080-7716-SE13 | 05-09-2013 | Fresenius Kabi Chile Limitada | $1.428.000 |
| 2080-6074-SE13 | 03-09-2013 | Fresenius Kabi Chile Limitada | $3.570.000 |
| 2080-7488-SE13 | 26-08-2013 | Pfizer Chile S.A. | $1.309.000 |
| 2080-7435-SE13 | 23-08-2013 | Etex Farmaceutica Limitada | $121.975 |
| 2080-6080-SE13 | 07-08-2013 | Tecnofarma S.A. | $680.680 |
| 2080-6078-SE13 | 30-07-2013 | Pfizer Chile S.A. | $1.309.000 |
| 2080-6076-SE13 | 29-07-2013 | Etex Farmaceutica Limitada | $121.975 |
| 2080-6081-SE13 | 26-07-2013 | Laboratorios Recalcine S.A. | $273.105 |
| 2080-6082-SE13 | 15-07-2013 | Laboratorios Recalcine S.A. | $680.680 |
Fuente original:ficha mercadopublico.cl
